Tirzepatide, a dual GLP-1 and GIP receptor agonist, has shown significant weight loss results in clinical trials, but some patients report muscle or joint discomfort during their first weeks of treatment
Clinical practice should increasingly focus on: Body composition assessment Adequate protein intake Resistance exercise Strategies to preserve skeletal muscle during weight loss #GLP1 #Obesity #Sarcopenia #ClinicalNutrition #BodyComposition #MuscleHealth #ObesityMedicine To view or add a comment, sign in Another breakthrough
meglio usare Taurina e L-Carnitina insieme
Muscle carnitine deficiency Muscle carnitine deficiency findings are limited to muscle and can be associated with proximal weakness and signs of exercise intolerance and cardiomyopathy
Talk to your doctor if your symptoms of fatigue continue or are severe
Why choose the Toxin Zoomer PFAS (Forever Chemicals) Heavy Metals Are heavy metals affecting my energy, mood, or inflammation